ISPOR Asia Pacific Summit 2026
6-8 September
-
CLINICAL AND COST-EFFECTIVENESS OF EMPEGFILGRASTIM VERSUS FILGRASTIM FOR FEBRILE NEUTROPENIAPROPHYLAXIS IN LYMPHOMA PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY: A REAL-WORLD STUDY
Jul 9, 2026, 19:56 PM -
CLINICAL BURDEN AND HEALTH-RELATED QUALITY OF LIFE IN CERVICAL CANCER ACROSS FIVE HIGH-BURDEN ASIA-PACIFIC COUNTRIES: A TARGETED LITERATURE REVIEW...
Jul 9, 2026, 19:56 PM -
PSYCHOTROPIC DRUG USE IN SHANDONG’S PUBLIC HOSPITALS (2022-2024): GROWTH, COST TRENDS, AND REGIONAL DISPARITIES UNDER NATIONAL VOLUME BASED PROCUREMENT...
Jul 9, 2026, 19:56 PM -
CLINICAL COST-EFFECTIVENESS ANALYSIS OF NAAT DIAGNOSTICS FOR ACTIVE TB DIAGNOSIS AND RIFAMPICIN RESISTANCE TESTING IN PUBLIC PRIMARY HEALTHCARE IN INDIA
Jul 9, 2026, 19:56 PM -
COST-UTILITY ANALYSIS OF LEFT ATRIAL APPENDAGE OCCLUDER DEVICES FOR ATRIAL FIBRILLATION PATIENTS WITH CONTRAINDICATIONS TO ORAL ANTICOAGULATION THERAPY IN THAILAND...
Jul 9, 2026, 19:56 PM -
COST-EFFECTIVENESS OF HIGH-DOSE INFLUENZA VACCINE STRATEGIES FOR OLDER ADULTS IN JAPAN
Jul 9, 2026, 19:56 PM -
ANTIMICROBIAL STEWARDSHIP POLICY IMPLEMENTATION DURING COVID-19 PANDEMIC: A NATIONWIDE SERIAL CROSS-SECTIONAL STUDY
Jul 9, 2026, 19:56 PM -
" SMART SAFETY : INTEGRATING AI WITH THE MATERIOVIGILANCE CAUSALITY ASSESSMENT TOOL FOR ENHANCED MEDICAL DEVICE MONITORING"
Jul 9, 2026, 19:56 PM -
ACCESS PLAN FOR DRUG DEVELOPMENT
Jul 9, 2026, 19:56 PM -
EVOLVING USE AND ACCEPTANCE OF REAL-WORLD EVIDENCE WITHIN HTA IN JAPAN BY MANUFACTURERS AND THE ATAG: INSIGHTS FROM C2H REPORTS
Jul 9, 2026, 19:56 PM -
COST-EFFECTIVENESS OF INFLUENZA VACCINE IN REDUCING HOSPITALIZATIONS AND MORTALITY IN THE ELDERLY POPULATION IN INDIA...
Jul 9, 2026, 19:56 PM -
CHINA'S NATIONAL VOLUME-BASED PROCUREMENT: EFFECTS ON DRUG PRICES AND PUBLIC PROCUREMENT SPENDING
Jul 9, 2026, 19:56 PM -
HEALTH-RELATED QUALITY OF LIFE TRAJECTORIES AFTER ACUTE STROKE: A 90-DAY PROSPECTIVE LONGITUDINAL COHORT STUDY
Jul 9, 2026, 19:56 PM -
IMPACT OF SCREEN TIME AND SCREEN CONTENT ON ADHD SYMPTOMS IN SCHOOL-AGED CHILDREN: AN ANALYTICAL CROSS-SECTIONAL STUDY IN QUETTA...
Jul 9, 2026, 19:56 PM -
COST-EFFECTIVENESS ANALYSIS OF DURVALUMAB AS FIRST-LINE TREATMENT FOR NON-SMALL CELL LUNG CANCER IN JAPAN
Jul 9, 2026, 19:56 PM -
COST-EFFECTIVENESS OF COLORECTAL CANCER SCREENING STRATEGIES IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Jul 9, 2026, 19:56 PM -
ACCELERATING ONCOLOGY EVIDENCE SYNTHESIS: A MULTI-LLM FRAMEWORK FOR AUTOMATED SYSTEMATIC LITERATURE REVIEW SCREENING...
Jul 9, 2026, 19:56 PM -
DELAYING INTRACRANIAL PROGRESSION IN NSCLC BRAIN METASTASES: CLINICAL AND PATIENT-CENTERED VALUE...
Jul 9, 2026, 19:56 PM -
CROSS-AGENCY APPRAISAL OF REAL-WORLD EVIDENCE IN ONCOLOGY AND RARE DISEASE DRUG-INDICATION HTA APPRAISALS ACROSS SELECT APAC MARKETS AND ENGLAND: A COMPARATIVE HTA APPRAISAL REVIEW (2021-2026)
Jul 9, 2026, 19:56 PM -
IS THE U.S. MOST FAVORED NATION (MFN) INITIATIVE EXPECTED TO AFFECT DRUG LAUNCHES IN KOREA...
Jul 9, 2026, 19:56 PM